Director Charles Faith L. buys 7,100 CNSP shares at $4.79; company unprofitable with $-4.9M net income
Charles Faith L., a director, purchased 7,100 shares at $4.79 on 2026-05-18, representing his first holding in the security. The purchase occurs in an unprofitable company: CNS Pharmaceuticals reported net income of $-4,937,046.00 over its most recent full fiscal year, with a market cap of $6,985,726.22. The stock is currently 71.1% below its 52-week high of $16.56, having rallied 88.2% over the past 30 days. Across his cross-ticker open-market history, the insider has achieved a 100.00% 90-day win rate with an average 90-day return of 53.4%, though this track record provides limited predictive value for CNSP-specific outcomes given the absence of prior same-ticker history.